Johnson & Johnson suspended sales forecasts for its Covid-19 vaccine during the American pharmaceutical giant's quarterly earnings call Tuesday, as demand lags behind that of shots by Moderna and Pfizer.

Johnson & Johnson suspends sales forecast for Covid vaccine

US health regulators said on Friday that use of Johnson & Johnson Covid vaccine could restart. The rollout of the vaccine was paused due to worries over blood clotting.

US regulators approve restarting use of Johnson & Johnson Covid vaccine

European countries prepared on Wednesday to resume deliveries of Johnson & Johnson's COVID-19 vaccine and speed up the rollout after Europe's drug regulator backed the shot.

European countries to resume J&J COVID vaccine deliveries

Denmark's health authority said on Wednesday it expects to announce its decision on how to proceed with Johnson & Johnson's COVID-19 vaccine next week pending f

Denmark to decide on Johnson & Johnson COVID-19 shot next week

The Centers for Disease Control and Prevention has decided to extend the pause imposed on emergency use of the Johnson & Johnson (J&J) vaccine in the US as the researchers felt there is a lack of data on the rare blood clotting side effect.

US continues pause on Johnson & Johnson vaccine over reports of blood clots

Johnson & Johnson has started testing its Covid-19 vaccine on adolescents. The young people, beginning with those aged 16 and 17, will be added to an ongoing study of the vaccine in adults that began last September, the drugmaker said Friday.

Johnson & Johnson starts testing its Covid vaccine on teens

Health Minister Jens Spahn said Friday that Germany would have to wait until "mid-to-late April" for the newly approved Johnson & Johnson coronavirus vaccine, adding that the EU is querying the company over the delays.

Germany expects Johnson & Johnson jabs only in April

The European Union on Thursday approved Johnson & Johnson's single-dose coronavirus vaccine, as the bloc seeks to speed up a stuttering inoculation campaign and boost its supplies of vaccines.

European Union gives green light to Johnson & Johnson's COVID-19 vaccine

Johnson & Johnson's COVID-19 vaccine has become embroiled in a controversy as the Catholic Archdiocese of New Orleans have labelled it as “morally compromised” over links to abortion cells.

Johnson & Johnson vaccine gets embroiled in controversy over abortion cells

A day after the US authorised Johnson & Johnson's coronavirus vaccine for emergency use, the authorities are now hoping that four million doses of the vaccine will be delivered across the country as early as Tuesday.

US to get 4 million J&J vaccine by Tuesday; Fauci hopes to vaccinate children by 2021 end

Dr. Anthony Fauci, the top US infectious disease official, said on Sunday he would take the newly approved Johnson & Johnson COVID-19 vaccine, as he encouraged Americans to accept any of the three approved shots.

Fauci urges Americans to get any of the three COVID-19 vaccines available

On Saturday, the US authorised Johnson & Johnson's coronavirus vaccine for emergency use, making it the third approved vaccine of the county since the outbreak of COVID-19 a year ago.

As US approves Johnson & Johnson coronavirus vaccine, Biden warns Americans

South Africa's second tranche of 80,000 Johnson & Johnson COVID-19 vaccine from Brussels touched down at OR Tambo International airport on Saturday morning. The second batch of vaccines is reserved for frontline healthcare workers.

South Africa receives second batch of J&J vaccines

An advisory panel to US Food and Drug Administration (FDA) on Friday (February 26) greenlit Johnson & Johnson's COVID-19 vaccine. The vaccine has gort nod for emergency use.

USFDA advisory panel clears Johnson & Johnson's COVID-19 vaccine

Johnson & Johnson on Thursday applied for emergency use authorisation of its single-dose coronavirus vaccine to US health regulators. If approved, the vaccine will be third for the worst-hit United States, the country which has seen over 450,000 deaths due to the deadly virus.

Johnson & Johnson seeks emergency use authorisation for its Covid-19 vaccine